Rotavirus vaccine inducing heterotypic cross protection

Details for Australian Patent Application No. 2006281566 (hide)

Owner GlaxoSmithKline Biologicals S.A.

Inventors Colau, Brigitte Desiree Alberte; De Vos, Beatrice Arsene Virginie

Agent Shelston IP

Pub. Number AU-B-2006281566

PCT Pub. Number WO2007/020078

Priority 0608962.7 05.05.06 GB; 0516944.6 17.08.05 GB; 0521164.4 18.10.05 GB

Filing date 15 August 2006

Wipo publication date 22 February 2007

Acceptance publication date 1 September 2011

International Classifications

A61K 39/15 (2006.01) Medicinal preparations containing antigens or antibodies - Reoviridae, e.g. calf diarrhea virus

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

Event Publications

6 March 2008 PCT application entered the National Phase

  PCT publication WO2007/020078 Priority application(s): WO2007/020078

1 September 2011 Application Accepted

  Published as AU-B-2006281566

12 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006281569-Composition and method for determination of CK19 expression

2006281562-A polyolefin foam